RINGER LACTATE BAXTER infusioonilahus Eesti - eesti - Ravimiamet

ringer lactate baxter infusioonilahus

baxter healthcare limited - elektrolüüdid - infusioonilahus - 250ml 30tk; 500ml 1tk; 1000ml 10tk; 250ml 1tk; 1000ml 1tk

Tyenne Euroopa Liit - eesti - EMA (European Medicines Agency)

tyenne

fresenius kabi deutschland gmbh - totsilizumab - arthritis, rheumatoid; cytokine release syndrome; arthritis, juvenile rheumatoid; covid-19 virus infection; giant cell arteritis - immunosupressandid - tyenne, in combination with methotrexate (mtx), is indicated for- the treatment of severe, active and progressive rheumatoid arthritis (ra) in adults not previously treated with mtx. - the treatment of moderate to severe active ra in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (dmards) or tumour necrosis factor (tnf) antagonists. in these patients, tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tocilizumab has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. tyenne is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. tyenne is indicated for the treatment of active systemic juvenile idiopathic arthritis (sjia) in patients 1 year of age and older, who have responded inadequately to previous therapy with nsaids and systemic corticosteroids. tyenne can be given as monotherapy (in case of intolerance to mtx or where treatment with mtx is inappropriate) or in combination with mtx. tyenne in combination with methotrexate (mtx) is indicated for the treatment of juvenile idiopathic polyarthritis (pjia; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with mtx. tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tyenne is indicated for the treatment of chimeric antigen receptor (car) t cell-induced severe or life-threatening cytokine release syndrome (crs) in adults and paediatric patients 2 years of age and older. tyenne is indicated for the treatment of giant cell arteritis (gca) in adult patients.

TruScient Euroopa Liit - eesti - EMA (European Medicines Agency)

truscient

zoetis belgium sa - dibotermiin alfa - luu morfogeneetilised valgud - koerad - osteoinduktiivne aine, mida kasutatakse pikkade luumurdude raviks standardse kirurgilise hoolduse lisana, kasutades koertel avatud luumurdude vähenemist.

Rilonacept Regeneron (previously Arcalyst) Euroopa Liit - eesti - EMA (European Medicines Agency)

rilonacept regeneron (previously arcalyst)

regeneron uk limited - rilonacept - cryopyrin-associated perioodilised sündroomid - immunosupressandid - rilonacept regeneron näitab tõsised sümptomid, sealhulgas perekondliku külma auto-põletikuline sündroomi (fcas) ja muckle-wells sündroomi (mws), cryopyrin seotud perioodiliste sündroomide (caps) raviks täiskasvanutel ja lastel vanuses 12 aastat ja vanemate.

Dinolytic süstelahus Eesti - eesti - Ravimiamet

dinolytic süstelahus

zoetis belgium - dinoprost - süstelahus - 12,5mg 1ml 10ml 1tk

Ketofen 10% süstelahus Eesti - eesti - Ravimiamet

ketofen 10% süstelahus

ceva sante animale - ketoprofeen - süstelahus - 100mg 1ml 100ml 1tk; 100mg 1ml 50ml 1tk

BELKYRA süstelahus Eesti - eesti - Ravimiamet

belkyra süstelahus

abbvie sia - deoksükoolhape - süstelahus - 10mg 1ml 2ml 4tk

FORVEL süste-/infusioonilahus Eesti - eesti - Ravimiamet

forvel süste-/infusioonilahus

medochemie limited - naloksoon - süste-/infusioonilahus - 0,4mg 1ml 5tk; 0,4mg 1ml 10tk

PRISMASOL 4 MMOL/L KAALIUM hemodialüüsi-/hemofiltratsioonilahus Eesti - eesti - Ravimiamet

prismasol 4 mmol/l kaalium hemodialüüsi-/hemofiltratsioonilahus

baxter holding b.v. - kaltsiumkloriiddihüdraat+magneesiumkloriidheksahüdraat+glükoos+piimhape+naatriumkloriid+naatriumvesinikkarbonaat+kaaliumkloriid - hemodialüüsi-/hemofiltratsioonilahus - 1,75mmol+0,5mmol+6,1mmol+3mmol+105mmol+32mmol+4mmol 1l 5000ml 2tk

PRISMASOL 2 MMOL/L KAALIUM hemodialüüsi-/hemofiltratsioonilahus Eesti - eesti - Ravimiamet

prismasol 2 mmol/l kaalium hemodialüüsi-/hemofiltratsioonilahus

baxter holding b.v. - kaltsiumkloriiddihüdraat+magneesiumkloriidheksahüdraat+glükoos+piimhape+naatriumkloriid+naatriumvesinikkarbonaat+kaaliumkloriid - hemodialüüsi-/hemofiltratsioonilahus - 1,75mmol+0,5mmol+6,1mmol+3mmol+105mmol+32mmol+2mmol 1l 5000ml 2tk